Sign in
WithdrawnPhase 4

Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients

Key facts

Who runs it
National Institute of Cardiovascular Diseases, Pakistan
Trial code
Status
Withdrawn
Phase
Phase 4
Started
19 Dec 2022
Ended
17 Jan 2025
Type of study
Interventional
Treatments tested
  • Aminophylline Injection
Record updated
25 May 2025
Why it stopped
we could not find patients fulfilling all of our inclusion criteria

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adult patients admitted with recent acute inferior wall myocardial infarction (MI)
  • Hemodynamically stable blood pressure
  • Complete heart block with Narrow QRS < 120 ms and ventricular rate >40/min persisting for at least 6 hours, resistant to atropine
  • Temporary pacemaker (TPM) already placed
  • Patient asymptomatic with a mean arterial pressure of greater than 65 mmHg with TPM rate placed at 40/min

Who cannot take part

  • Patients with a prior history of AV block
  • Known liver disease (cirrhosis, hepatitis)
  • Drugs with dromotropic effects (beta blocker, calcium channel blocker, inotropes)
  • Patients with cardiogenic shock
  • Patients with preexisting permanent pacemaker and Implantable Cardioverter Defibrillator (ICD)
  • Hypothyroidism
  • Unable to consent

About the trial

What the trial wants to find out

In this study, the investigator will evaluate the rate of reversal of complete heart block with aminophylline in atropine resistant patients with inferior wall myocardial infarction (MI)

The group in the trial

  • Treatment groupTreatment being tested

    Patients receiving Injection Aminophylline

    Treatment: Aminophylline Injection

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessing the Impact of Aminophylline in the Reversal of Complete Heart Block Secondary to Inferior Wall MI in Atropine Resistant Patients: An Open Label Non-randomized Clinical Trial
Record updated
25 May 2025